Page 121 - Biomarkers for risk stratification and guidance in heart failure
P. 121
Chapter 5
REFERENCES
1. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. Euroheart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:2725-36.
2. Harjola VP, Follath F, Nieminen MS, Brutsaert D, Dickstein K, Drexler H, et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 2010;12:239-48.
3. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315-22.
4. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-Terminal-proebrain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110: 2168e74.
5. O’Brien RJ, Squire IB, Demme B, Davies JE, Ng LL. Pre-discharge, but not admission, levels of NT- proBNP predict adverse prognosis following acute LVF. Eur J Heart Fail 2003;5:499-506.
6. Masson S, Latini R, Anand IS, Barlera S, Angelici L, Vago T, et al. Prognostic value of changes in N-terminal proebrain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). J Am Coll Cardiol 2008;52:997-1003.
7. Bruins S, Fokkema MR, Romer JW, Dejongste MJ, van der Dijs FP, van den Ouweland JM, et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 2004;50:2052-8.
8. Eurlings LW, van Pol PE, Kok WE, van Wijk S, Lodewijks-van der Bolt C, Balk AH, et al. Management of chronic heart failure guided by individual N-terminal proeB-type natriuretic peptide targets: results of the PRIMA (Can ProeBrain-Natriuretic peptide-guided Therapy of Chronic Heart Failure Improve Heart Failure Morbidity and Mortality?) study. J Am Coll Cardiol 2010;56:2090-100.
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70.
10. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007;49:1943- 50.
11. Kubler P, Jankowska EA, Majda J, Reczuch K, Banasiak W, Ponikowski P. Lack of decrease in plasma N-terminal proebrain natriuretic peptide identifies acute heart failure patients with very poor outcome. Int J Cardiol 2008;129:373-8.
12. Knebel F, Schimke I, Diaz Ramirez I, Schattke S, Eddicks S, Borges AC, et al. Hemodynamic improvement of acutely decompensated heart failure patients is associated with decreasing levels of NT-proBNP. Int J Cardiol 2009;134:260-3.
13. Moertl D, Hammer A, Huelsmann M, Pacher R, Berger R. Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patients. Eur J Heart Fail 2008;10:404-11.
14. Bayes-Genis A, Pascual-Figal D, Fabregat J, Domingo M, Planas F, Casas T, et al. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. Int J Cardiol 2007;120: 338-43.
15. Araujo JP, Azevedo A, Lourenco P, Rocha-Goncalves F, Ferreira A, Bettencourt P. Intraindividual variation of amino-terminal proeB-type natriuretic peptide levels in patients with stable heart failure. Am J Cardiol 2006;98:1248-50.
16. Frankenstein L, Remppis A, Frankenstein J, Hess G, Zdunek D, Slottje K, et al. Variability of N-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables. Clin Chem 2009;55:923-9.
17. O’Hanlon R, O’Shea P, Ledwidge M, O’Loughlin C, Lange S, Conlon C, et al. The biologic variability of B-type natriuretic peptide and N-terminal proeB-type natriuretic peptide in stable heart failure patients. J Card Fail 2007;13:50-5.
120
